Published in Br J Clin Pharmacol on May 01, 1999
Spironolactone reduces brachial pulse wave velocity and PIIINP levels in hypertensive diabetic patients. Br J Clin Pharmacol (2005) 0.89
Pharmacological treatment of chronic heart failure. Heart Fail Rev (2006) 0.79
Aldosterone and the autocrine modulation of potassium currents and oxidative stress in the diabetic rat heart. Br J Pharmacol (2008) 0.79
Don't keep that ACE (inhibitor) up your sleeve! Is ramipril effective for secondary prevention of cardiovascular disease and stroke? Can Fam Physician (2000) 0.75
Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med (1985) 5.09
QT dispersion and sudden unexpected death in chronic heart failure. Lancet (1994) 4.17
Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation (1998) 3.99
Sensitivity and specificity of QTc dispersion for identification of risk of cardiac death in patients with peripheral vascular disease. BMJ (1996) 2.43
Repolarization dispersion and sudden cardiac death in patients with impaired left ventricular function. Eur Heart J (1997) 2.27
Intake of potassium, magnesium, calcium, and fiber and risk of stroke among US men. Circulation (1998) 1.94
Aldosterone blunts the baroreflex response in man. Clin Sci (Lond) (1998) 1.60
Aldosterone reduces baroreceptor discharge in the dog. Hypertension (1992) 1.54
Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J Mol Cell Cardiol (1993) 1.49
QT and QTc dispersion are accurate predictors of cardiac death in newly diagnosed non-insulin dependent diabetes: cohort study. BMJ (1998) 1.41
Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations. Circulation (1995) 1.37
Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis. Am J Cardiol (1995) 1.34
Normalization of acquired QT prolongation in humans by intravenous potassium. Circulation (1997) 1.31
Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients. Cardiovasc Res (1997) 1.24
Beneficial effects of vagal stimulation and bradycardia during experimental acute myocardial ischemia. Circulation (1974) 1.24
Protective effect of vagal stimulation on reperfusion arrhythmias in cats. Circ Res (1987) 1.20
Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol (1995) 0.98
Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure. J Card Fail (1996) 0.97
Ectopic arrhythmia provoking action of aldosterone. Life Sci (1962) 0.93
Chronic administration of aldosterone depresses baroreceptor reflex function in the dog. Hypertension (1994) 0.91
Heart rate variability in left ventricular dysfunction and heart failure: effects and implications of drug treatment. Br Heart J (1994) 0.86
Effects of long-term oral magnesium chloride replacement in congestive heart failure secondary to coronary artery disease. Am J Cardiol (1993) 0.84
Diurnal variations of plasma aldosterone in supine man: relationship to plasma renin activity and plasma cortisol. Acta Endocrinol (Copenh) (1975) 0.79